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Abstract 
Nicotinamide nucleotide transhydrogenase constitutes a proton pump which links the NAD(H) and NADP(H) pools in the 
cell by catalyzing a reversible reduction of NADP + by NADH. The recent cloning and characterization of several 
proton-pumping transhydrogenases how that they share a number of features. They are composed of three domains, i.e., the 
hydrophilic domains I and III containing the NAD(H)- and NADP(H)-binding sites, respectively, and domain II containing 
the transmembrane and proton-conducting region. When expressed separately, the two hydrophilic domains interact directly 
and catalyze hydride transfer reactions similar to those catalyzed by the wild-type enzyme. An extensive mutagenesis 
program has established several amino acid residues as important for both catalysis and proton pumping. Conformational 
changes mediating the redox-driven proton pumping by the enzyme are being characterized. With the cloned, well- 
characterized and easily accessible transhydrogenases from E. coli and Rhodospirillum rubrum at hand, the overall aim of 
the transhydrogenase research, the understanding of the conformationally driven proton pumping mechanism, is within 
reach. © 1998 Elsevier Science B.V. 
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1. Introduction 
Proton-pumping nicotinamide nucleotide trans- 
hydrogenase (E.C. 1.6.1.1) catalyzes the reaction 
+ _.._~ + 
Ho~ t + NADH + NADP ~ain q- NAD ÷ + NADPH 
(1) 
where 'out' and 'in' denote the cytosol and matrix, 
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respectively, in mitochondria nd periplasmic space 
and cytosol, respectively, in bacteria. It is the only 
enzyme that transfers hydride ions between the NAD 
and NADP pools in eukaryotes and certain bacteria, 
and thus regulates directly the balance between 
NAD(P)-linked anabolism and catabolism. Trans- 
hydrogenase from Escherichia coli is composed of an 
subunit of about 54 kDa and a 13 subunit of 48 kDa, 
and an active form of 0£282 . The enzyme catalyzes 
the reversible reduction of NADP by NADH linked 
to the translocation of one proton (cf. Ref. [1]) 
according to reaction (1). 
Despite being a membrane protein, transhydrogen- 
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ase is relatively simple to isolate and purify, at least 
from bovine and E. coli, in a reconstitutively active 
form. The bovine transhydrogenase was the first to be 
purified and characterized, and this enzyme provided 
the basis for a series of studies which established 
transhydrogenase s a dimeric and conformationally 
driven proton pump, independent of other membrane 
proteins. (for early reviews see Refs. [2,3]). Sub- 
sequently, transhydrogenase r search has been 
strongly facilitated by the cloning of E. coli trans- 
hydrogenase and overexpressing the transhydrogen- 
ase gene more than 70-fold by Bragg and co-workers 
[4,5], which has made it possible to produce large 
amounts of the E. coli enzyme in a pure and stable 
state. In addition, the system has allowed an exten- 
sive mutagenesis program. Thus, even though other 
transhydrogenases have later been cloned and over- 
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Fig. 1. Topology model of E. coli transhydrogenase (A) and an alignment 
of domains for bovine, E. tenella, E. coli and R. rubrum transhydrogen- 
ases (B). 
expressed, the E. coli transhydrogenase possesses a
number of advantages with regard to suitability for 
molecular biology studies and as a model for other 
transhydrogenases (for recent reviews see Refs. [6- 
8]). 
Like all proton-pumping transhydrogenases theE. 
coli enzyme is composed of three domains, i.e., the 
hydrophilic domain I (~1-404) containing the 
NADH-binding site, the hydrophobic domain II 
(et405-[3260) containing the membrane-spanning et- 
helices, and the hydrophilic domain III ([3261-13462) 
containing the NADP(H)-binding site. A cartoon and 
a domain alignment for difference transhydrogenases 
are shown in Fig. 1. About 10 transhydrogenase 
genes have been cloned and sequenced todate, which 
show an overall sequence identity of about 23%. 
Recently, the genes of the soluble AA subunit of R. 
rubrum transhydrogenase [9], domain I from E. coli 
[10,11], and domain III of E. coli [11,12], bovine 
([12], see also Ref. [13]) and R. rubrum [12,14] have 
been overexpressed and the gene product isolated and 
characterized. When combined, tightly associated 
domain I and III catalyze a slow reverse reaction 
(reduction of NAD + or the substrate analogue 3- 
acetylpyridine-NAD + (AcPyAD+), by NADPH), but 
a fast so-called cyclic reduction of AcPyAD + by 
NADH mediated by bound NADP(H). 
2. Domains involved in proton translocation 
Whereas hydride ion transfer occurs directly be- 
tween the NAD(H)-binding site in domain I and the 
NADP(H)-binding site in domain III without any 
intermediate [15], proton translocation obviously 
requires the membrane part of the enzyme, domain II. 
Both the ot subunit and the [3 subunit contribute with 
at least four and six a-helices, respectively, to 
domain II of E. coli transhydrogenase [16,17] (Fig. 
2). In the model of the transmembrane a-helices in E. 
coli transhydrogenase, themain uncertainties are in 
the [3 subunit, i.e., a possible helix preceding helix 1, 
and the helices following helix 3. 13H91 is the only 
conserved charged residue in the predicted trans- 
membranous helices of domain II and, comparable to 
the single Asp-61 of the c-subunit of, e.g.E, coli 
F 1F o-ATPase [ 18], and has therefore been suggested 
to constitute the periplasmic end of a proton wire 
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Fig. 2. Model of the transmembrane s ctor (domain II) of E. coli transhydrogenase. The extension of four and 10 transmembrane helices of the a and 13 
subunits, respectively, are indicated by horizontal arrows. 
[1,7]. Another component of the hypothetical proton 
wire in the 13 subunit has been proposed to be the 
13D392 residue close to or in the NADP(H)-binding 
site [19]. Thus, all residues potentially associated 
with proton pumping found so far are located in the 13 
subunit. This raises the question whether the four 
a-helices of the a subunit, predicted with a high 
certainty [16], have any role in proton pumping. In 
the bovine enzyme, Triton X-100 alone was shown to 
reversibly dissociate the active dimer into inactive 
monomers [20], suggesting the possibility that hydro- 
phobic interactions may also be important for interac- 
tions between the et and 13 subunits in the E. coli 
enzyme. Indirect support for this view comes from 
the inefficient interaction between the purified do- 
mains I and HI from E. coli [11], in contrast to the 
very efficient and tight binding between the soluble 
subunit AA and domain III in R. rubrum [14]. E. coli 
transhydrogenase needs the hydrophobic interaction 
between the membrane helices of both the a and 13 
subunits in order to make interactions between do- 
main I and III possible. Subunit AA lacks the four 
transmembrane a-helices (cf. Fig. 1) and the stabiliz- 
ing interaction of these a-helices with domain III in 
vivo, and is therefore assumed to need to bind much 
more strongly by itself to the hydrophilic region in 
domain III. As a working hypothesis, it is therefore 
assumed that the four a-helices of the a subunit has a 
structural role in keeping the NAD(H)- and 
NADP(H)-binding sites together, allowing an effi- 
cient hydride transfer, and that they have no direct 
role in proton pumping or proton conductance. 
By using a cysteine-free E. coli transhydrogenase 
[1], the specific introduction of cysteines demon- 
strated that the a subunits in the a2132 interact along 
a surface that includes positions aC395 and aC397, 
since the cysteines form disulphides and crosslinked 
a 2 dimers [21]. By this technique surfaces between 
the two oL and the two 13 subunits, as well as that 
between the ct and 13 subunits, can be established in 
the absence and in the presence of substrates, as well 
as conformational changes involving altered inter- 
subunit surfaces. 
Removal of the 2'-OH group of NADH, generating 
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2'-deoxy-NADH, inhibits catalysis and proton pump- 
ing but does not eliminate these activities [22]. 
Likewise, reduced nicotinamide mononucleotide 
(NMNH), i.e. NADH minus the adenine mononu- 
cleotide moiety, can reduce thio-NADP ÷. In a recon- 
stituted system where Ap was generated by bacterior- 
hodopsin, a slight but significant stimulation of this 
reactions was observed, suggesting that the 
adenosine-5'-phosphate moiety of NAD(H) is not 
required for proton pumping (J. Zhang, X. Hu, and J. 
Rydstr6m, unpublished data). 
Cloning and expression of domain I and III opened 
up the possibility to further investigate the influence 
of domain II on transhydrogenase reactions. With R. 
rubrum domain I and III, a rapid cyclic reaction was 
obtained which depended on the presence of approxi- 
mately one tightly bound NADP(H)/domain III [14]. 
This bound NADP(H) was present in domain III 
when isolated. Domain I contained no bound 
NAD(H). The forward and reverse reactions were 
catalyzed very poorly by the combined R. rubrum 
domain I and III, in agreement with the limiting 
dissociation of NADP(H). Clearly, the lacking do- 
main II has therefore normally a pronounced regula- 
tory effect on both domains, or at least domain III, in 
the intact enzyme, influencing primarily the dissocia- 
tion of NADP(H) [23]. This view is consistent with 
the possibility that indeed [3H91 in the [3 subunit part 
of domain II contributes to the effects of Ap on the 
NADP(H)-binding site. 
3. Role of specific residues in catalysis and 
proton pumping 
There is only one predicted inucleotide-binding 
[3tx[3-fold in domain I of E. coli transhydrogenase, the
structure of which has been 3D-modelled on the basis 
of homologue dehydrogenases/reductases with 
known structures [24]. Mutagenesis of the residues of 
the consensus GXGXXG sequence (etG191-otG196) 
led to a complete or partial inhibition, in agreement 
with mutagenesis of various dehydrogenases [24]. 
Likewise, mutation of 13G314, i.e., the first glycine in 
the corresponding GXGXXA sequence of the 
NADP(H)-binding site in domain III, led as expected 
to a complete inhibition [25]. The 5'-(p-fluorosul- 
fonylbenzoyl) adenosine (FSBA)- and N,N'- 
dicyclohexylcarbodiimide (DCCD)-reactive tyrosine 
and aspartic/glutamic a id residues in both domain I 
and III were identified and found not to be essential 
[26,27]. Recently, conserved histidines and arginines 
in the NADP(H)-binding site, e.g. 13H345 and 
[3R350, were studied of which the latter were sug- 
gested to be important for catalysis but not for 
binding [28,29]. 
A direct link has previously been established 
between the nature of the [391 residue and the affinity 
of the NADP(H) site for NADP(H), e.g. the [3H91K 
mutation leads to a high cyclic activity and an 
increased trypsin sensitivity, in both cases in the 
absence of added NADP(H), due to bound NADP(H) 
[30-32]. Since [3H91 may be assumed to be located 
in the predicted helix 7 (Fig. 2), i.e., presumably far 
from the NADP(H)-binding site in domain III, it is 
apparent hat [3H91 regulates the properties of the 
NADP(H)-binding site through long-distance con- 
formational changes and vice versa, and also fulfils 
the requirements for part of a proton wire [7]. Similar 
to, e.g. bacteriorhodopsin, where mutagenesis of 
residues known to be involved in proton pumping do 
not lead to a complete inhibition [33], some mutants 
of [3H91 also show activity with regard to proton 
pumping. This is explained by the relatively low rate 
of proton pumping required through the proton wire, 
which allows other protonable groups (serines, 
threonines, etc.) and/or water molecules, to partially 
substitute for [3H91. A proton-pumping mechanism 
involving [3H9l, proposed earlier [7], is shown in 
Fig. 3. 
Another acidic group potentially involved in a 
proton wire on the cytosolic side is [3D392 [19], 
which probably is located close to, or in the 
NADP(H) site [7]. In contrast to 13H91, mutation of 
this residue led to a pronounced inhibition of all 
activities except for the [3D392A mutant which 
showed a relatively high NADP(H)-dependent cyclic 
activity and a very low reverse reaction [19]. Even 
though it has not yet been possible to determine the 
possible proton-pumping activity of [3D392A, it is 
assumed that, as a working hypothesis, both 13H91 
and [3D392 form part of a proton wire, possibly 
constituting the two ends of this wire. 
In a recent effort to introduce specific, e.g. fluores- 
cent NEM-linked probes, a cysteine-free E. coli 
transhydrogenase was generated [1]. In the cysteine- 
14 J. Rydstriirn et al. / Biochimica et Biophysica Acta 1365 (1998) 10-16 
out 
NADPH 
NAD + 
NADP+~ 
NADH 
1A .NADPH H+in ~ 2A _NADPH 
3B NADPH 3A NADP+ 
+H -X - -~ i ~  X'H + 
NAD + NADH 
1B I NADP+ 
"× 
NADH H+ou t 
~" NADH 
Fig. 3. Reaction mechanism of proton-pumping transhydrogenase. The residue 'X' is assumed to be [3H91. The numbers 1A, IB, 2A, 2B, 3A and 3B 
denote different conformational states. Modified from Ref. [7]. 
free background cysteines can be specifically in- 
serted, which then can be reacted with the NEM 
derivatives probing local environments around e.g. 
[3H91 and [3D392. This is an extremely promising 
system that has not yet been fully explored. 
4. Conformational states in transhydrogenase- 
catalyzed reactions 
Conformational changes were early recognized as 
essential in the coupling between hydride transfer and 
proton pumping by transhydrogenase [2]. This con- 
clusion was initially based on the dramatic affinity 
changes of the bovine enzyme for its substrates in 
submitochondrial particles exposed to a Ap [2,3]. 
Already at this time these results suggested that 
alterations in the binding of substrates were conveyed 
through the protein via long-range conformational 
changes to a proton wire that carried protons through 
the protein [2,3]. Additional support for especially 
NADP(H)-dependent conformational changes was 
provided by altered temperature, DCCD and protease 
sensitivities of the bovine enzyme [2,6]. 
Following the cloning of the E. coli transhydrogen- 
ases it became possible to identify the trypsin cleav- 
age sites in both the a and [3 subunits. Whereas the 
subunit contains everal cleavage sites regardless of 
the presence or absence of NAD(H), the [3 subunit is 
cleaved in positions [3R265 and [3K363 only in the 
presence of NADP(H) [34]. These positions are 
flanking the postulated NADP(H)-binding site in 
which the GXGXXA of the possible [3al3-fold [7] 
starts with the essential [3G314 residue. Apparently, 
NADPH provides a higher protease sensitivity than 
NADP + (O. Fjellstr6m, unpublished data), suggesting 
that the conformational states induced by NADPH 
and NADP + are different. In general, NAD(P) + and 
NAD(P)H are indeed likely to induce different 
conformational states in most dehydrogenases/reduc- 
tases and related inucleotide-dependent enzymes (cf. 
Ref. [35]). In addition, it was recently found that the 
isolated domain III from E. coli behaved physically 
different in the presence of NADPH and NADP + 
[11]. Taken together, the available vidence therefore 
strongly suggests that the conformational states in- 
duced by binding of NADPH and NADP + are 
different. 
A key question is then whether the above NADPH- 
and NADP+-induced conformational states are rel- 
evant for proton pumping. As a working hypothesis 
we assume that they are, but except for the link 
between [3H91 and the NADP(H)-binding site, a 
solid direct experimental evidence for this is pres- 
ently lacking. However, the directionality of the 
transhydrogenase reaction and the associated proton 
pumping, as described in Eq. (1) is obviously depen- 
dent on the redox states of NAD(H) and NADP(H), 
respectively. Eliminating NAD(H) from this context 
for the reasons given above, leaves NADP(H) as the 
decisive redox component. 
In a recent theoretical treatment of the trans- 
hydrogenase, constituting a continuation of an earlier 
suggestion that proton pumping was governed by the 
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release of NADPH and NADP + [23], Jackson and 
co-workers suggested that all intermediates of the 
cyclic reaction involve essentially the same con- 
formational state, denoted as TH** [36]. They also 
provided an elegant explanation for the differences 
between various transhydrogenases with regard to the 
requirements for a cyclic reaction to occur. A previ- 
ous proposal by Rydstr6m and co-workers [7,19,22] 
suggested that NADPH and NADP ÷ determine the 
exposure of a proton wire to the periplasmic space 
and cytosol, respectively, in bacteria, essentially as 
described in Fig. 3. In this model the cyclic reaction, 
i.e., the cyclic reduction of AcPyAD + by NADH via 
bound NADP(H) as described in Fig. 4, would 
involve a minimum of the conformationally different 
states 2A, 3A, 2B and 3B in Fig. 3, in which the 
protonation state of 13H91 is crucial. At low pH (pH 
6.0 or below), which is a requirement for the cyclic 
reaction to be catalyzed by E. coli transhydrogenase, 
[3H91 will not be deprotonated during the cycle and 
no net proton pumping occurs [22]. However, the 
model also implies that the alternative access of the 
proton wire to the two sides of the membrane is 
governed by the redox state of NADP(H) during the 
cycle. 
The molecular mechanism of proton pumping by 
transhydrogenase remains unknown. However, as- 
suming that domain III is primarily involved, it is 
possible that the amide group of the nicotinamide 
moiety of NADP + and the positive charge of the 
nicotine, alter the pK a of a nearby protonable residue. 
This results in a protonation of this latter residue 
(stronger in the presence of an external Ap) from the 
periplasmic space, an activation of the bound NADP + 
leading to an increased redox potential in the 4 
position, and an acceptance of a hydride ion from 
NADH. Subsequently, the proton is released on the 
cytosolic side of the membrane concomitantly with 
NADH 
NADP +, E ~ It- NADP ÷, E * NADH ~- NADPH • E ,  NAD ÷ 
AcPyAD + NAD+ 
NADP + , E .  AcPyADH -~ NADPH , E ,  AcPyAD +-~ NADPH , E 
Fig. 4. Cyclic reaction catalyzed by E. coli transhydrogenase. The
NADP(H) indicated in bold text remains bound during the cycle. From 
Ref.  [43]. 
NADPH. Even though a similar mechanism was 
proposed earlier including specific residues [40], the 
residues involved have so far still not been finally 
identified. 
5. Recent trends in research on the role of 
transhydrogenase 
Recent studies of the correlation between, e.g. 
redox level of mitochondrial NADP(H), electron 
transport, Ca z+ and apoptosis, have led to a renewed 
interest in mitochondrial systems regulating 
NADP(H) [37-39]. Therefore, attempts to clarify the 
physiological function of transhydrogenase, primarily 
in eucaryotes, have increased and are being ap- 
proached mainly by studies in intact tissues, gene 
expression and gene knockout. For the reasons de- 
scribed above, there is also a growing medical/phar- 
maceutical interest in transhydrogenase. Presently, 
three theoretical functional roles dominate, i.e.: (i) 
maintenance of a high redox buffer of NADPH for 
biosynthesis, detoxication purposes and regulation of 
redox-systems [41]; (ii) an amplification by trans- 
hydrogenase of the regulation of the Krebs cycle 
through the NAD+-dependent isocitrate dehydrogen- 
ase [42], and (iii) generation of a short-term Ap in 
ischemia/anoxia [41]. These alternatives are pres- 
ently being tested in various laboratories, including 
their implications for human disease. There is also a 
growing interest in organisms that lack trans- 
hydrogenase, .g. yeast, and attempts to provide such 
organisms with transhydrogenase in order to improve 
specific functions in, e.g. biotechnology applications. 
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